Rainbow Children's Medicare Ltd
Rainbow Children's Medicare Ltd (RAINBOW) last traded at ₹1,445, a market capitalisation of ₹14,676 crore, on a P/E of 51.2. Over the past 52 weeks the stock has ranged between ₹1,009 and ₹1,610. Rainbow Children's Medicare Ltd last reported results for the quarter ended Jun 2026, with sales of ₹470 crore and net profit of ₹63 crore. Figures are as of 25 Aug 2026 and are not real time.
Rainbow Children's Medicare Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Rainbow Children's Medicare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹470 cr, up 33.1% from ₹353 cr a year earlier. Net profit was ₹63 cr, up 16.7% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 417 | 398 | 370 | 353 | 445 | 445 | 460 | 470 |
| Expenses | 270 | 264 | 255 | 249 | 296 | 298 | 315 | 335 |
| Operating profit | 147 | 134 | 115 | 104 | 149 | 147 | 145 | 135 |
| OPM % | 35% | 34% | 31% | 29% | 33% | 33% | 31% | 29% |
| Other income | 11 | 13 | 15 | 20 | 8 | 11 | 4 | 13 |
| Interest | 18 | 18 | 18 | 18 | 19 | 20 | 20 | 21 |
| Depreciation | 35 | 35 | 34 | 34 | 36 | 40 | 41 | 42 |
| Profit before tax | 105 | 94 | 77 | 71 | 102 | 98 | 87 | 84 |
| Tax % | 25% | 27% | 27% | 25% | 26% | 24% | 10% | 26% |
| Net profit | 79 | 69 | 57 | 54 | 76 | 74 | 78 | 63 |
| EPS (₹) | 7.77 | 6.76 | 5.55 | 5.27 | 7.41 | 7.14 | 7.59 | 5.96 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Rainbow Children's Medicare Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 650 | 974 | 1,174 | 1,297 | 1,516 | 1,703 | 1,820 |
| Operating profit | 165 | 308 | 400 | 432 | 494 | 548 | 575 |
| OPM % | 25% | 32% | 34% | 33% | 33% | 32% | 32% |
| Net profit | 40 | 139 | 212 | 218 | 244 | 282 | 290 |
| EPS (₹) | 9.10 | 14.70 | 20.77 | 21.38 | 23.97 | 27.40 | 28.10 |
TTM is the trailing twelve months to the most recent quarter.
Rainbow Children's Medicare Ltd growth and returns
- 10 Years
- 22%
- 5 Years
- 21%
- 3 Years
- 13%
- TTM
- 18%
- 10 Years
- 31%
- 5 Years
- 44%
- 3 Years
- 6%
- TTM
- 11%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 12%
- 1 Year
- -4%
- 10 Years
- 17%
- 5 Years
- 19%
- 3 Years
- 17%
- Last Year
- 16%
Rainbow Children's Medicare Ltd shareholding pattern
Promoters held 49.84% at Jun 2026, broadly unchanged since Jun 2025. FIIs 16.03% and DIIs 22.56%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 49.85% | 49.85% | 49.85% | 49.85% | 49.85% | 49.84% | 49.84% | 49.84% |
| FIIs | 25.12% | 25.12% | 23.69% | 23.60% | 21.85% | 19.24% | 17.24% | 16.03% |
| DIIs | 13.84% | 13.87% | 15.31% | 15.44% | 17.46% | 19.49% | 21.12% | 22.56% |
| Public | 11.20% | 11.16% | 11.14% | 11.11% | 10.82% | 11.40% | 11.68% | 11.39% |
| No. of shareholders | 77,524 | 78,764 | 79,092 | 80,320 | 81,134 | 88,809 | 88,561 | 89,305 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Rainbow Children's Medicare Ltd corporate filings
- Resignation of Mr. Vikas Maheshwari as Chief Financial Officer of the Company w.e.f. August 31, 2026Company Updatelow impact
Cruxal's analysis: Rainbow Children's Medicare Limited has formally announced the resignation of its Chief…
Read the full analysis - Update on acquisitionCompany Updatemedium impact
Cruxal's analysis: Rainbow Children’s Medicare Limited has successfully finalized the acquisition of a 64%…
Read the full analysis - Earnings Call Transcript for the quarter ended June 30, 2026Company Updatemedium impact
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Rainbow Children's Medicare Ltd
Cruxal reads every Rainbow Children's Medicare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.